logo

New malaria vaccine shows great promise in early clinical trials

Malaria is the leading deadly disease on the continent, killing more than 400,000 people a year. A potential malaria vaccine has proven to be about 77 per cent effective in early clinical trials, suggesting it could be a possible breakthrough in the fight against the disease. Professor Halidou Tinto, Principal Investigator of the vaccine trial spoke with CNBC Africa for more.


Mon Apr 26 2021 | 14:52:23 GMT+0000 (Coordinated Universal Time)

Share

Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent. Sign up here.